Honoured to be among the top influencers at #EAU2024 , reflecting our collective efforts to amplify the voices of people affected by #BladderCancer . It's a testament to the work of the amazing people at Fight Bladder Cancer and the World Bladder Cancer Patient Coalition #Urology

🌟 Congratulations to our president for being recognised as a top influencer at #EAU2024 !

Your efforts & leadership continue to drive our mission forward, amplifying the voices of those affected by #BladderCancer !

Such a fantastic group. I’m honoured to have been invited! #BladderCancer ✊🏻

USC Urology journal club with the best mentor Sia Daneshmand, M.D.!
Great discussion on recent #BladderCancer papers with #mediterranean food! 🥘👨🏻‍💻🥗
Thank you Chinchilla Joan for coordinating this special night!

Come see our MD Anderson Cancer Center Society of Urologic Oncology #OncSurgery fellows presenting #BladderCancer research at #AUA24

Valentina Grajales MD, MS Amanda Myers Wei Shen Tan Alexis Steinmetz Côme Tholomier Alberto Martini

It’s Monday #BladderCancer & #RareGUTumors Clinic ⁦National Cancer Institute⁩ ⁦NCI Center for Cancer Research⁩ ⁦NIH Clinical Center⁩. Happy Monday from the team! ⁦Nicholas Simon⁩ ⁦Elias Chandran, MBBS⁩ ⁦Dr. Andre R. Kydd⁩ ⁦Saad Atiq⁩ #EndCancer #CancerResearchSavesLives

Say hello to the new standard of care #BladderCancer $IBRX
vimeo.com/938278849

Adstiladrin was originally approved by the FDA for its current indication in December 2022.

#BladderCancer #genetherapy #oncology Ferring Pharmaceuticals

Read more:

cgtlive.com/view/ferring-l…

🔥⬇️ Pls make sure to check the work of our terrific #UroOnc fellows of MD Anderson Cancer Center (@AmandaMyersMD Wei Shen Tan Valentina Grajales MD, MS Côme Tholomier) at Amer. Urol. Assn. #AUA24 !
Happy for rewarding collaboration in #BladderCancer topics w/ unmet needs; mentorship of Omar Alhalabi, MD & Ashish M. Kamat, MD, MBBS!

The anticipated #WorldGU24 meeting is coming to NYC this August. We are thrilled to have Dr. Matt Milowsky discuss the latest #bladdercancer advancements. Learn more: hubs.la/Q02tJ01k0 #genitourinarycancers #CME

📽️ You can watch here the latest updates on #bladdercancer presented at #EAU24
🔴 Thanks ecancer ecancer_espanol for the interview
🔝 A pleasure to share stage with Bernadett Szabados Andrea Necchi Johann Loriot & Cosimo De Nunzio
EAU Edu Platform UROONCO GUO-AEU
t.ly/NnXB-

Thanks Bladder Cancer Advocacy Network for always looking for ways to improve care for #BladderCancer patients! #AUA24

CEA (CEACAM5) expression is common in muscle-invasive urothelial carcinoma of the bladder but unrelated to the disease course
#BladderCancer Henning Plage et al

doi.org/10.1002/bco2.3…

Great to have yet another option for our #bladdercancer patients!

Bladder Cancer Advocacy Network

⚡️ Predicting non-muscle invasive bladder cancer outcomes using artificial intelligence: a systematic review using APPRAISE-AI

#BladderCancer #AI

nature.com/articles/s4174…

Been out a while, but better late tweet than never; NPEPPS as target in #cisplatin resistant #bladdercancer in Cancer Research ! By Robert Jones , Tahlita Zuiverloon MD PhD , Dan Theodorescu , Jim Costello. congrats!
NPEPPS Is a Druggable Driver of Platinum Resistance aacrjournals.org/cancerres/arti…

Marcelo Wroclawski giving a superb lecture on what’s new on #bladdercancer w/ Professor Joan Palou Redorta also on stage #uro .onco24

We're excited to join Bladder Cancer Advocacy Network at the first 2024 Walk to End Bladder Cancer in #Philadelphia on 4/27! Every step supports individuals affected with #bladdercancer across the US.

Join us either in-person or virtually from any city, now through May: bit.ly/3x65qD3

Advances bring new immunotherapy and targeted therapy options for non-muscle invasive #BladderCancer . KMittaloncMD University of Massachusetts & Guru P. Sonpavde, MD AdventHealth Central Florida discuss recent advances and ongoing #ClinicalTrials in this space > bit.ly/3RNjYiy UMass Memorial Health

CURE® spoke with Dr. Jean Hoffman-Censits of Johns Hopkins Kimmel Cancer Center about a recent phase 3 trial evaluating the survival benefits of Padcev plus Keytruda versus chemotherapy in patients with advanced #BladderCancer .

Read the article here: curetoday.com/view/padcev-ke…